ad image

T-Cell

1 / 1
Soligenix, Inc.
Clinical CRO

HyBryte™ Expanded Treatment Continues to Demonstrate Positive Outcomes in Early-Stage Cutaneous T-Cell Lymphoma

Soligenix, Inc.

PR-01-25-NI-10Jan 14, 2025
Allogeneic T Cell Therapies: Efficient Commercial Manufacturing Readiness using “Manufacturing by Design” Methodology
Cell Therapy

Allogeneic T Cell Therapies: Efficient Commercial Manufacturing Readiness using “Manufacturing by Design” Methodology

Catalent

PAO-12-20-CL-01Dec 16, 2020
Bayer
Strategic Collaboration

Bayer and Atara Biotherapeutics Enter Strategic Collaboration for Mesothelin-Targeted CAR T-cell Therapies for Solid Tumors

Bayer

PR-M11-20-030Dec 10, 2020
Combating Cancer and Other Diseases with Supercharged NKT Cells
Natural Killer T cells

Combating Cancer and Other Diseases with Supercharged NKT Cells

Theresa Deisher, Ph.D.

AVM Biotechnology

PAP-Q4-20-CL-005Dec 09, 2020
NantKwest — Harnessing Natural Killer Cells to Treat Cancer
In Conversation

NantKwest — Harnessing Natural Killer Cells to Treat Cancer

Emilie Branch; Patrick Soon-Shiong, M.D.

Pharma's Almanac

PAP-Q1-20-CL-016Mar 19, 2020
Promoting T-Cell Survival
T-Cell

Promoting T-Cell Survival

Pharma's Almanac

PAO-M07-19-NI-008Jul 01, 2019
Syntrix Pharmaceuticals
Immunotherapy

Researchers Report SX-682 Could Enhance Multiple Forms of T Cell-Based Immunotherapies in Solid Tumors

Syntrix Pharmaceuticals

PR-M04-19-NI-040Apr 11, 2019
Tumor Derived T cells Demonstrate Potential Against Ovarian Cancer
Oncology

Tumor Derived T cells Demonstrate Potential Against Ovarian Cancer

Marc Technow

Nice Insight

PAO-M03-18-NI-020Mar 23, 2018
Thermo Fisher Gets Key Customer for Its Cell Therapy Activation Reagents
CAR T

Thermo Fisher Gets Key Customer for Its Cell Therapy Activation Reagents

Nice Insight

PAO-M01-18-NI-006Jan 04, 2018
Memory T Cells Fit to be Cross Trained
Drug Development

Memory T Cells Fit to be Cross Trained

Nice Insight

PAO-M12-17-NI-027Dec 19, 2017
Magnetic Bead Technology Activates Novartis’ CAR-T Therapy
Partnership

Magnetic Bead Technology Activates Novartis’ CAR-T Therapy

Nigel Walker

Nice Insight

PAO-M09-17-NI-007Sep 05, 2017
Research Collaboration Will Focus on the Development of New CAR T-Cell Treatments
Innovation

Research Collaboration Will Focus on the Development of New CAR T-Cell Treatments

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-M07-17-NI-007Jul 07, 2017
1 / 1